TGF-β Regulation of T Cells

Literature Cited

1. 1.

   Sporn MB. 2006. The early history of TGF-beta, and a brief glimpse of its future. Cytokine Growth Factor Rev. 17:3–7
   [Google Scholar]
2. 2.

   Mosmann TR, Coffman RL. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145–73
   [Google Scholar]
3. 3.

   Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100:655–69
   [Google Scholar]
4. 4.

   Zhu J, Paul WE. 2010. Peripheral CD4⁺ T-cell differentiation regulated by networks of cytokines and transcription factors. Immunol. Rev. 238:247–62
   [Google Scholar]
5. 5.

   Dong C. 2008. T_H17 cells in development: an updated view of their molecular identity and genetic programming. Nat. Rev. Immunol. 8:337–48
   [Google Scholar]
6. 6.

   Littman DR, Rudensky AY. 2010. Th17 and regulatory T cells in mediating and restraining inflammation. Cell 140:845–58
   [Google Scholar]
7. 7.

   Kaplan MH, Hufford MM, Olson MR. 2015. The development and in vivo function of T helper 9 cells. Nat. Rev. Immunol. 15:295–307
   [Google Scholar]
8. 8.

   Sakaguchi S. 2000. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101:455–58
   [Google Scholar]
9. 9.

   Crotty S. 2011. Follicular helper CD4 T cells (T_FH). Annu. Rev. Immunol. 29:621–63
   [Google Scholar]
10. 10.

    Jameson SC, Masopust D. 2018. Understanding subset diversity in T cell memory. Immunity 48:214–26
    [Google Scholar]
11. 11.

    Kok L, Masopust D, Schumacher TN. 2022. The precursors of CD8⁺ tissue resident memory T cells: from lymphoid organs to infected tissues. Nat. Rev. Immunol. 22:283–93
    [Google Scholar]
12. 12.

    Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP et al. 2013. Innate lymphoid cells—a proposal for uniform nomenclature. Nat. Rev. Immunol. 13:145–49
    [Google Scholar]
13. 13.

    Cheroutre H, Lambolez F, Mucida D. 2011. The light and dark sides of intestinal intraepithelial lymphocytes. Nat. Rev. Immunol. 11:445–56
    [Google Scholar]
14. 14.

    Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L. 2004. NKT cells: What's in a name?. Nat. Rev. Immunol. 4:231–37
    [Google Scholar]
15. 15.

    Roberts AB, Anzano MA, Lamb LC, Smith JM, Sporn MB. 1981. New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. PNAS 78:5339–43
    [Google Scholar]
16. 16.

    Chen W, Ten Dijke P. 2016. Immunoregulation by members of the TGFβ superfamily. Nat. Rev. Immunol. 16:723–40
    [Google Scholar]
17. 17.

    Massague J. 1996. TGFβ signaling: receptors, transducers, and Mad proteins. Cell 85:947–50
    [Google Scholar]
18. 18.

    Bandyopadhyay B, Fan J, Guan S, Li Y, Chen M et al. 2006. A “traffic control” role for TGFβ3: orchestrating dermal and epidermal cell motility during wound healing. J. Cell Biol. 172:1093–105
    [Google Scholar]
19. 19.

    Wu L, Siddiqui A, Morris DE, Cox DA, Roth SI, Mustoe TA. 1997. Transforming growth factor β3 (TGFβ3) accelerates wound healing without alteration of scar prominence: histologic and competitive reverse-transcription-polymerase chain reaction studies. Arch. Surg. 132:753–60
    [Google Scholar]
20. 20.

    Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M et al. 1993. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. PNAS 90:770–74
    [Google Scholar]
21. 21.

    Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ et al. 1992. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359:693–99
    [Google Scholar]
22. 22.

    Li MO, Sanjabi S, Flavell RA. 2006. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25:455–71
    [Google Scholar]
23. 23.

    Liu Y, Zhang P, Li J, Kulkarni AB, Perruche S, Chen W 2008. A critical function for TGF-beta signaling in the development of natural CD4⁺CD25⁺Foxp3⁺ regulatory T cells. Nat. Immunol. 9:632–40
    [Google Scholar]
24. 24.

    Marie JC, Liggitt D, Rudensky AY. 2006. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity 25:441–54
    [Google Scholar]
25. 25.

    Takimoto T, Wakabayashi Y, Sekiya T, Inoue N, Morita R et al. 2010. Smad2 and Smad3 are redundantly essential for the TGF-beta-mediated regulation of regulatory T plasticity and Th1 development. J. Immunol. 185:842–55
    [Google Scholar]
26. 26.

    Derynck R, Zhang YE. 2003. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425:577–84
    [Google Scholar]
27. 27.

    Letterio JJ, Roberts AB. 1998. Regulation of immune responses by TGF-β. Annu. Rev. Immunol. 16:137–61
    [Google Scholar]
28. 28.

    Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. 2006. Transforming growth factor-β regulation of immune responses. Annu. Rev. Immunol. 24:99–146
    [Google Scholar]
29. 29.

    Massague J. 1996. TGFβ signaling: receptors, transducers, and Mad proteins. Cell 85:947–50
    [Google Scholar]
30. 30.

    Rubtsov YP, Rudensky AY. 2007. TGFβ signalling in control of T-cell-mediated self-reactivity. Nat. Rev. Immunol. 7:443–53
    [Google Scholar]
31. 31.

    Travis MA, Sheppard D. 2014. TGF-β activation and function in immunity. Annu. Rev. Immunol. 32:51–82
    [Google Scholar]
32. 32.

    Moreau JM, Velegraki M, Bolyard C, Rosenblum MD, Li Z. 2022. Transforming growth factor-β1 in regulatory T cell biology. Sci. Immunol. 7:eabi4613
    [Google Scholar]
33. 33.

    Shevach EM. 2017. Garp as a therapeutic target for modulation of T regulatory cell function. Expert Opin. Ther. Targets 21:191–200
    [Google Scholar]
34. 34.

    Pesu M, Watford WT, Wei L, Xu L, Fuss I et al. 2008. T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance. Nature 455:246–50
    [Google Scholar]
35. 35.

    Sorrentino A, Thakur N, Grimsby S, Marcusson A, von Bulow V et al. 2008. The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat. Cell Biol. 10:1199–207
    [Google Scholar]
36. 36.

    Yamashita M, Fatyol K, Jin C, Wang X, Liu Z, Zhang YE 2008. TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. Mol. Cell 31:918–24
    [Google Scholar]
37. 37.

    Chen W, Konkel JE. 2015. Development of thymic Foxp3⁺ regulatory T cells: TGF-beta matters. Eur. J. Immunol. 45:958–65
    [Google Scholar]
38. 38.

    Klein L, Robey EA, Hsieh CS. 2019. Central CD4⁺ T cell tolerance: deletion versus regulatory T cell differentiation. Nat. Rev. Immunol. 19:7–18
    [Google Scholar]
39. 39.

    Konkel JE, Jin W, Abbatiello B, Grainger JR, Chen W 2014. Thymocyte apoptosis drives the intrathymic generation of regulatory T cells. PNAS 111:E465–73
    [Google Scholar]
40. 40.

    Ouyang W, Beckett O, Ma Q, Li MO 2010. Transforming growth factor-beta signaling curbs thymic negative selection promoting regulatory T cell development. Immunity 32:642–53
    [Google Scholar]
41. 41.

    Konkel JE, Maruyama T, Carpenter AC, Xiong Y, Zamarron BF et al. 2011. Control of the development of CD8αα⁺ intestinal intraepithelial lymphocytes by TGF-β. Nat. Immunol. 12:312–19
    [Google Scholar]
42. 42.

    Etzensperger R, Kadakia T, Tai X, Alag A, Guinter TI et al. 2017. Identification of lineage-specifying cytokines that signal all CD8⁺-cytotoxic-lineage-fate ‘decisions’ in the thymus. Nat. Immunol. 18:1218–27
    [Google Scholar]
43. 43.

    Ouyang W, Oh SA, Ma Q, Bivona MR, Zhu J, Li MO. 2013. TGF-beta cytokine signaling promotes CD8⁺ T cell development and low-affinity CD4⁺ T cell homeostasis by regulation of interleukin-7 receptor alpha expression. Immunity 39:335–46
    [Google Scholar]
44. 44.

    Takada K, Jameson SC. 2009. Naive T cell homeostasis: from awareness of space to a sense of place. Nat. Rev. Immunol. 9:823–32
    [Google Scholar]
45. 45.

    Jenkins MK. 1994. The ups and downs of T cell costimulation. Immunity 1:443–46
    [Google Scholar]
46. 46.

    Tu E, Chia CPZ, Chen W, Zhang D, Park SA et al. 2018. T cell receptor-regulated TGF-beta type I receptor expression determines T cell quiescence and activation. Immunity 48:745–59.e6
    [Google Scholar]
47. 47.

    Flavell RA, Sanjabi S, Wrzesinski SH, Licona-Limon P. 2010. The polarization of immune cells in the tumour environment by TGFβ. Nat. Rev. Immunol. 10:554–67
    [Google Scholar]
48. 48.

    Gorelik L, Flavell RA. 2002. Transforming growth factor-beta in T-cell biology. Nat. Rev. Immunol. 2:46–53
    [Google Scholar]
49. 49.

    Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL et al. 2005. Interleukin 17-producing CD4⁺ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6:1123–32
    [Google Scholar]
50. 50.

    Park H, Li Z, Yang XO, Chang SH, Nurieva R et al. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6:1133–41
    [Google Scholar]
51. 51.

    Korn T, Bettelli E, Oukka M, Kuchroo VK. 2009. IL-17 and Th17 Cells. Annu. Rev. Immunol. 27:485–517
    [Google Scholar]
52. 52.

    Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421:744–48
    [Google Scholar]
53. 53.

    Bettelli E, Carrier Y, Gao W, Korn T, Strom TB et al. 2006. Reciprocal developmental pathways for the generation of pathogenic effector T_H17 and regulatory T cells. Nature 441:235–38
    [Google Scholar]
54. 54.

    Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC et al. 2006. Transforming growth factor-beta induces development of the T_H17 lineage. Nature 441:231–34
    [Google Scholar]
55. 55.

    Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. 2006. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179–89
    [Google Scholar]
56. 56.

    Chen W, Jin W, Hardegen N, Lei KJ, Li L et al. 2003. Conversion of peripheral CD4⁺CD25⁻ naive T cells to CD4⁺CD25⁺ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198:1875–86
    [Google Scholar]
57. 57.

    Zhou L, Littman DR. 2009. Transcriptional regulatory networks in Th17 cell differentiation. Curr. Opin. Immunol. 21:146–52
    [Google Scholar]
58. 58.

    Yang XO, Panopoulos AD, Nurieva R, Chang SH, Wang D et al. 2007. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 282:9358–63
    [Google Scholar]
59. 59.

    Ghoreschi K, Laurence A, Yang XP, Hirahara K, O'Shea JJ. 2011. T helper 17 cell heterogeneity and pathogenicity in autoimmune disease. Trends Immunol. 32:395–401
    [Google Scholar]
60. 60.

    Zhang S, Takaku M, Zou L, Gu AD, Chou WC et al. 2017. Reversing SKI-SMAD4-mediated suppression is essential for TH17 cell differentiation. Nature 551:105–9
    [Google Scholar]
61. 61.

    Maruyama T, Li J, Vaque JP, Konkel JE, Wang W et al. 2011. Control of the differentiation of regulatory T cells and T_H17 cells by the DNA-binding inhibitor Id3. Nat. Immunol. 12:86–95
    [Google Scholar]
62. 62.

    Zhang F, Fuss IJ, Yang Z, Strober W 2014. Transcription of RORγt in developing Th17 cells is regulated by E-proteins. Mucosal Immunol. 7:521–32
    [Google Scholar]
63. 63.

    Tanaka S, Jiang Y, Martinez GJ, Tanaka K, Yan X et al. 2018. Trim33 mediates the proinflammatory function of Th17 cells. J. Exp. Med. 215:1853–68
    [Google Scholar]
64. 64.

    Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. 1998. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Investig. 101:890–98
    [Google Scholar]
65. 65.

    Kasagi S, Zhang P, Che L, Abbatiello B, Maruyama T et al. 2014. In vivo-generated antigen-specific regulatory T cells treat autoimmunity without compromising antibacterial immune response. Sci. Transl. Med. 6:241ra78
    [Google Scholar]
66. 66.

    Perruche S, Zhang P, Liu Y, Saas P, Bluestone JA, Chen W 2008. CD3-specific antibody-induced immune tolerance involves transforming growth factor-beta from phagocytes digesting apoptotic T cells. Nat. Med. 14:528–35
    [Google Scholar]
67. 67.

    Esplugues E, Huber S, Gagliani N, Hauser AE, Town T et al. 2011. Control of T_H17 cells occurs in the small intestine. Nature 475:514–18
    [Google Scholar]
68. 68.

    Zhang D, Jin W, Wu R, Li J, Park SA et al. 2019. High glucose intake exacerbates autoimmunity through reactive-oxygen-species-mediated TGF-beta cytokine activation. Immunity 51:671–81.e5
    [Google Scholar]
69. 69.

    Gutcher I, Donkor MK, Ma Q, Rudensky AY, Flavell RA, Li MO. 2011. Autocrine transforming growth factor-β1 promotes in vivo Th17 cell differentiation. Immunity 34:396–408
    [Google Scholar]
70. 70.

    Diveu C, McGeachy MJ, Cua DJ. 2008. Cytokines that regulate autoimmunity. Curr. Opin. Immunol. 20:663–68
    [Google Scholar]
71. 71.

    Ahern PP, Schiering C, Buonocore S, McGeachy MJ, Cua DJ et al. 2010. Interleukin-23 drives intestinal inflammation through direct activity on T cells. Immunity 33:279–88
    [Google Scholar]
72. 72.

    Ghoreschi K, Laurence A, Yang XP, Tato CM, McGeachy MJ et al. 2010. Generation of pathogenic T_H17 cells in the absence of TGF-beta signalling. Nature 467:967–71
    [Google Scholar]
73. 73.

    Lee Y, Awasthi A, Yosef N, Quintana FJ, Xiao S et al. 2012. Induction and molecular signature of pathogenic T_H17 cells. Nat. Immunol. 13:991–99
    [Google Scholar]
74. 74.

    Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. 2007. Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8:942–49
    [Google Scholar]
75. 75.

    Chen Z, Tato CM, Muul L, Laurence A, O'Shea JJ. 2007. Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum. 56:2936–46
    [Google Scholar]
76. 76.

    van Beelen AJ, Zelinkova Z, Taanman-Kueter EW, Muller FJ, Hommes DW et al. 2007. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 27:660–69
    [Google Scholar]
77. 77.

    Manel N, Unutmaz D, Littman DR. 2008. The differentiation of human T_H-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt. Nat. Immunol. 9:641–49
    [Google Scholar]
78. 78.

    Lu Y, Hong S, Li H, Park J, Hong B et al. 2012. Th9 cells promote antitumor immune responses in vivo. J. Clin. Investig. 122:4160–71
    [Google Scholar]
79. 79.

    Schmitt E, Germann T, Goedert S, Hoehn P, Huels C et al. 1994. IL-9 production of naive CD4⁺ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma. J. Immunol. 153:3989–96
    [Google Scholar]
80. 80.

    Dardalhon V, Awasthi A, Kwon H, Galileos G, Gao W et al. 2008. IL-4 inhibits TGF-beta-induced Foxp3⁺ T cells and, together with TGF-beta, generates IL-9⁺ IL-10⁺ Foxp3⁻ effector T cells. Nat. Immunol. 9:1347–55
    [Google Scholar]
81. 81.

    Veldhoen M, Uyttenhove C, van Snick J, Helmby H, Westendorf A et al. 2008. Transforming growth factor-beta ‘reprograms’ the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9:1341–46
    [Google Scholar]
82. 82.

    Beriou G, Bradshaw EM, Lozano E, Costantino CM, Hastings WD et al. 2010. TGF-beta induces IL-9 production from human Th17 cells. J. Immunol. 185:46–54
    [Google Scholar]
83. 83.

    Uyttenhove C, Brombacher F, Van Snick J. 2010. TGF-beta interactions with IL-1 family members trigger IL-4-independent IL-9 production by mouse CD4⁺ T cells. Eur. J. Immunol. 40:2230–35
    [Google Scholar]
84. 84.

    Wong MT, Ye JJ, Alonso MN, Landrigan A, Cheung RK et al. 2010. Regulation of human Th9 differentiation by type I interferons and IL-21. Immunol. Cell Biol. 88:624–31
    [Google Scholar]
85. 85.

    Angkasekwinai P, Chang SH, Thapa M, Watarai H, Dong C 2010. Regulation of IL-9 expression by IL-25 signaling. Nat. Immunol. 11:250–56
    [Google Scholar]
86. 86.

    Nakatsukasa H, Zhang D, Maruyama T, Chen H, Cui K et al. 2015. The DNA-binding inhibitor Id3 regulates IL-9 production in CD4⁺ T cells. Nat. Immunol. 16:1077–84
    [Google Scholar]
87. 87.

    Xiao X, Balasubramanian S, Liu W, Chu X, Wang H et al. 2012. OX40 signaling favors the induction of T_H9 cells and airway inflammation. Nat. Immunol. 13:981–90
    [Google Scholar]
88. 88.

    Kaplan MH. 2017. The transcription factor network in Th9 cells. Semin. Immunopathol. 39:11–20
    [Google Scholar]
89. 89.

    Elyaman W, Bassil R, Bradshaw EM, Orent W, Lahoud Y et al. 2012. Notch receptors and Smad3 signaling cooperate in the induction of interleukin-9-producing T cells. Immunity 36:623–34
    [Google Scholar]
90. 90.

    Tamiya T, Ichiyama K, Kotani H, Fukaya T, Sekiya T et al. 2013. Smad2/3 and IRF4 play a cooperative role in IL-9-producing T cell induction. J. Immunol. 191:2360–71
    [Google Scholar]
91. 91.

    Wang A, Pan D, Lee YH, Martinez GJ, Feng XH, Dong C. 2013. Cutting edge: Smad2 and Smad4 regulate TGF-β-mediated Il9 gene expression via EZH2 displacement. J. Immunol. 191:4908–12
    [Google Scholar]
92. 92.

    Wilhelm C, Turner JE, Van Snick J, Stockinger B. 2012. The many lives of IL-9: a question of survival?. Nat. Immunol. 13:637–41
    [Google Scholar]
93. 93.

    Fontenot JD, Gavin MA, Rudensky AY. 2003. Foxp3 programs the development and function of CD4⁺CD25⁺ regulatory T cells. Nat. Immunol. 4:330–36
    [Google Scholar]
94. 94.

    Hori S, Nomura T, Sakaguchi S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057–61
    [Google Scholar]
95. 95.

    Khattri R, Cox T, Yasayko SA, Ramsdell F. 2003. An essential role for Scurfin in CD4⁺CD25⁺ T regulatory cells. Nat. Immunol. 4:337–42
    [Google Scholar]
96. 96.

    Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H. 2005. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6:1219–27
    [Google Scholar]
97. 97.

    Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25): Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151–64
    [Google Scholar]
98. 98.

    Shevach EM. 2009. Mechanisms of foxp3⁺ T regulatory cell-mediated suppression. Immunity 30:636–45
    [Google Scholar]
99. 99.

    Chen WJ, Frank M, Jin WW, Lei KJ, Hardegen N, Wahl SM. 2001. TGF-β induces anergic/suppressor CD4⁺ CD25⁺ CTLA-4⁺ T cells. J. Leuk. Biol. 2001:Suppl.102 Abstr. )
    [Google Scholar]
100. 100.

     Yamagiwa S, Gray JD, Hashimoto S, Horwitz DA. 2001. A role for TGF-beta in the generation and expansion of CD4⁺CD25⁺ regulatory T cells from human peripheral blood. J. Immunol. 166:7282–89
     [Google Scholar]
101. 101.

     Cobbold SP, Castejon R, Adams E, Zelenika D, Graca L et al. 2004. Induction of foxP3⁺ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants. J. Immunol. 172:6003–10
     [Google Scholar]
102. 102.

     Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR, Neurath MF. 2004. Cutting edge: TGF-beta induces a regulatory phenotype in CD4⁺CD25⁻ T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172:5149–53
     [Google Scholar]
103. 103.

     Fu S, Zhang N, Yopp AC, Chen D, Mao M et al. 2004. TGF-β induces Foxp3 + T-regulatory cells from CD4 + CD25 − precursors. Am. J. Transplant. 4:1614–27
     [Google Scholar]
104. 104.

     Rao PE, Petrone AL, Ponath PD. 2005. Differentiation and expansion of T cells with regulatory function from human peripheral lymphocytes by stimulation in the presence of TGF-β. J. Immunol. 174:1446–55
     [Google Scholar]
105. 105.

     Zheng SG, Wang JH, Gray JD, Soucier H, Horwitz DA. 2004. Natural and induced CD4⁺CD25⁺ cells educate CD4⁺CD25⁻ cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. J. Immunol. 172:5213–21
     [Google Scholar]
106. 106.

     Benson MJ, Pino-Lagos K, Rosemblatt M, Noelle RJ. 2007. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 204:1765–74
     [Google Scholar]
107. 107.

     Coombes JL, Siddiqui KR, Arancibia-Carcamo CV, Hall J, Sun CM et al. 2007. A functionally specialized population of mucosal CD103⁺ DCs induces Foxp3⁺ regulatory T cells via a TGF-β– and retinoic acid–dependent mechanism. J. Exp. Med. 204:1757–64
     [Google Scholar]
108. 108.

     Josefowicz SZ, Niec RE, Kim HY, Treuting P, Chinen T et al. 2012. Extrathymically generated regulatory T cells control mucosal T_H2 inflammation. Nature 482:395–99
     [Google Scholar]
109. 109.

     Sun CM, Hall JA, Blank RB, Bouladoux N, Oukka M et al. 2007. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204:1775–85
     [Google Scholar]
110. 110.

     Mucida D, Park Y, Kim G, Turovskaya O, Scott I et al. 2007. Reciprocal T_H17 and regulatory T cell differentiation mediated by retinoic acid. Science 317:256–60
     [Google Scholar]
111. 111.

     Floess S, Freyer J, Siewert C, Baron U, Olek S et al. 2007. Epigenetic control of the foxp3 locus in regulatory T cells. PLOS Biol 5:e38
     [Google Scholar]
112. 112.

     Yue X, Trifari S, Aijo T, Tsagaratou A, Pastor WA et al. 2016. Control of Foxp3 stability through modulation of TET activity. J. Exp. Med. 213:377–97
     [Google Scholar]
113. 113.

     Yue X, Samaniego-Castruita D, Gonzalez-Avalos E, Li X, Barwick BG, Rao A. 2021. Whole-genome analysis of TET dioxygenase function in regulatory T cells. EMBO Rep 22:e52716
     [Google Scholar]
114. 114.

     Chen W, Frank ME, Jin W, Wahl SM 2001. TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity 14:715–25
     [Google Scholar]
115. 115.

     Chen X, Yang X, Yuan P, Jin R, Bao L et al. 2021. Modular immune-homeostatic microparticles promote immune tolerance in mouse autoimmune models. Sci. Transl. Med. 13:eaaw9668
     [Google Scholar]
116. 116.

     Chen Z, Zhang T, Kam HT, Qiao D, Jin W et al. 2021. Induction of antigen-specific Treg cells in treating autoimmune uveitis via bystander suppressive pathways without compromising anti-tumor immunity. eBioMedicine 70:103496
     [Google Scholar]
117. 117.

     Xu J, Liu O, Wang D, Wang F, Zhang D et al. 2022. In vivo generating SSA/Ro-antigen specific regulatory T cells improves experimental Sjögren's syndrome in mice. Arthritis Rheumatol 74:101699–705
     [Google Scholar]
118. 118.

     Zhang D, Chia C, Jiao X, Jin W, Kasagi S et al. 2017. d-Mannose induces regulatory T cells and suppresses immunopathology. Nat. Med. 23:1036–45
     [Google Scholar]
119. 119.

     Sakaguchi S, Miyara M, Costantino CM, Hafler DA. 2010. FOXP3⁺ regulatory T cells in the human immune system. Nat. Rev. Immunol. 10:490–500
     [Google Scholar]
120. 120.

     Amarnath S, Dong L, Li J, Wu Y, Chen W 2007. Endogenous TGF-beta activation by reactive oxygen species is key to Foxp3 induction in TCR-stimulated and HIV-1-infected human CD4⁺CD25⁻ T cells. Retrovirology 4:57
     [Google Scholar]
121. 121.

     Tran DQ, Ramsey H, Shevach EM. 2007. Induction of FOXP3 expression in naive human CD4⁺FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 110:2983–90
     [Google Scholar]
122. 122.

     Chen W, Jin W, Tian H, Sicurello P, Frank M et al. 2001. Requirement for transforming growth factor β1 in controlling T cell apoptosis. J. Exp. Med. 194:439–53
     [Google Scholar]
123. 123.

     Kawakami R, Kitagawa Y, Chen KY, Arai M, Ohara D et al. 2021. Distinct Foxp3 enhancer elements coordinate development, maintenance, and function of regulatory T cells. Immunity 54:947–61.e8
     [Google Scholar]
124. 124.

     Kim HP, Leonard WJ. 2007. CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J. Exp. Med. 204:1543–51
     [Google Scholar]
125. 125.

     Kitagawa Y, Ohkura N, Kidani Y, Vandenbon A, Hirota K et al. 2017. Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment. Nat. Immunol. 18:173–83
     [Google Scholar]
126. 126.

     Placek K, Hu G, Cui K, Zhang D, Ding Y et al. 2017. MLL4 prepares the enhancer landscape for Foxp3 induction via chromatin looping. Nat. Immunol. 18:1035–45
     [Google Scholar]
127. 127.

     Ruan Q, Kameswaran V, Tone Y, Li L, Liou HC et al. 2009. Development of Foxp3⁺ regulatory T cells is driven by the c-Rel enhanceosome. Immunity 31:932–40
     [Google Scholar]
128. 128.

     Tone Y, Furuuchi K, Kojima Y, Tykocinski ML, Greene MI, Tone M. 2008. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol. 9:194–202
     [Google Scholar]
129. 129.

     Zheng Y, Josefowicz S, Chaudhry A, Peng XP, Forbush K, Rudensky AY. 2010. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463:808–12
     [Google Scholar]
130. 130.

     Dikiy S, Li J, Bai L, Jiang M, Janke L et al. 2021. A distal Foxp3 enhancer enables interleukin-2 dependent thymic Treg cell lineage commitment for robust immune tolerance. Immunity 54:931–46.e11
     [Google Scholar]
131. 131.

     Chen W, Wahl SM. 2003. TGF-beta: the missing link in CD4⁺CD25⁺ regulatory T cell-mediated immunosuppression. Cytokine Growth Factor. Rev. 14:85–89
     [Google Scholar]
132. 132.

     Nakamura K, Kitani A, Strober W. 2001. Cell contact-dependent immunosuppression by CD4⁺CD25⁺ regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 194:629–44
     [Google Scholar]
133. 133.

     Stockis J, Colau D, Coulie PG, Lucas S 2009. Membrane protein GARP is a receptor for latent TGF-beta on the surface of activated human Treg. Eur. J. Immunol. 39:3315–22
     [Google Scholar]
134. 134.

     Azhar M, Yin M, Bommireddy R, Duffy JJ, Yang J et al. 2009. Generation of mice with a conditional allele for transforming growth factor beta 1 gene. Genesis 47:423–31
     [Google Scholar]
135. 135.

     Choi G, Kim BS, Chang JH, Chung Y. 2021. Defining the role of transforming growth factor β1 in Foxp3⁺ T regulatory cells. Immunity 54:393–94
     [Google Scholar]
136. 136.

     Turner JA, Stephen-Victor E, Wang S, Rivas MN, Abdel-Gadir A et al. 2020. Regulatory T cell-derived TGF-β1 controls multiple checkpoints governing allergy and autoimmunity. Immunity 53:1202–14.e6
     [Google Scholar]
137. 137.

     Velegraki M, Salem M, Ansa-Addo EA, Wu BX, Li Z. 2021. Autocrine transforming growth factor β1 in regulatory T cell biology—gone but not missed. Immunity 54:395–96
     [Google Scholar]
138. 138.

     Wang R, Zhu J, Dong X, Shi M, Lu C, Springer TA. 2012. GARP regulates the bioavailability and activation of TGFβ. Mol. Biol. Cell 23:1129–39
     [Google Scholar]
139. 139.

     Worthington JJ, Kelly A, Smedley C, Bauche D, Campbell S et al. 2015. Integrin αvβ8-mediated TGF-β activation by effector regulatory T cells is essential for suppression of T-cell-mediated inflammation. Immunity 42:903–15
     [Google Scholar]
140. 140.

     Travis MA, Reizis B, Melton AC, Masteller E, Tang Q et al. 2007. Loss of integrin α_vβ₈ on dendritic cells causes autoimmunity and colitis in mice. Nature 449:361–65
     [Google Scholar]
141. 141.

     Metelli A, Wu BX, Riesenberg B, Guglietta S, Huck JD et al. 2020. Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-β. Sci. Transl. Med. 12:eaay4860
     [Google Scholar]
142. 142.

     Koch MA, Tucker-Heard G, Perdue NR, Killebrew JR, Urdahl KB, Campbell DJ. 2009. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10:595–602
     [Google Scholar]
143. 143.

     Chaudhry A, Rudra D, Treuting P, Samstein RM, Liang Y et al. 2009. CD4⁺ regulatory T cells control T_H17 responses in a Stat3-dependent manner. Science 326:986–91
     [Google Scholar]
144. 144.

     Konkel JE, Zhang D, Zanvit P, Chia C, Zangarle-Murray T et al. 2017. Transforming growth factor-beta signaling in regulatory T cells controls T helper-17 cells and tissue-specific immune responses. Immunity 46:660–74
     [Google Scholar]
145. 145.

     Yang K, Kallies A. 2021. Tissue-specific differentiation of CD8⁺ resident memory T cells. Trends Immunol. 42:876–90
     [Google Scholar]
146. 146.

     Mishra S, Liao W, Liu Y, Yang M, Ma C et al. 2021. TGF-β and Eomes control the homeostasis of CD8⁺ regulatory T cells. J. Exp. Med. 218:e20200030
     [Google Scholar]
147. 147.

     McCarron MJ, Marie JC. 2014. TGF-beta prevents T follicular helper cell accumulation and B cell autoreactivity. J. Clin. Investig. 124:4375–86
     [Google Scholar]
148. 148.

     Kim YJ, Stringfield TM, Chen Y, Broxmeyer HE. 2005. Modulation of cord blood CD8⁺ T-cell effector differentiation by TGF-β1 and 4–1BB costimulation. Blood 105:274–81
     [Google Scholar]
149. 149.

     McKarns SC, Schwartz RH. 2005. Distinct effects of TGF-beta 1 on CD4⁺ and CD8⁺ T cell survival, division, and IL-2 production: a role for T cell intrinsic Smad3. J. Immunol. 174:2071–83
     [Google Scholar]
150. 150.

     Thomas DA, Massague J. 2005. TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell 8:369–80
     [Google Scholar]
151. 151.

     Budhu S, Schaer DA, Li Y, Toledo-Crow R, Panageas K et al. 2017. Blockade of surface-bound TGF-β on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment. Sci. Signal. 10:eaak9702
     [Google Scholar]
152. 152.

     Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K et al. 2018. TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554:544–48
     [Google Scholar]
153. 153.

     Tauriello DVF, Palomo-Ponce S, Stork D, Berenguer-Llergo A, Badia-Ramentol J et al. 2018. TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis. Nature 554:538–43
     [Google Scholar]
154. 154.

     Park BV, Freeman ZT, Ghasemzadeh A, Chattergoon MA, Rutebemberwa A et al. 2016. TGFβ1-media3ted SMAD3 enhances PD-1 expression on antigen-specific T cells in cancer. Cancer Discov. 6:366–81
     [Google Scholar]
155. 155.

     Alvarez M, Bouchlaka MN, Sckisel GD, Sungur CM, Chen M, Murphy WJ 2014. Increased antitumor effects using IL-2 with anti-TGF-β reveals competition between mouse NK and CD8 T cells. J. Immunol. 193:1709–16
     [Google Scholar]
156. 156.

     Bellavance EC, Kohlhapp FJ, Zloza A, O'Sullivan JA, McCracken J et al. 2011. Development of tumor-infiltrating CD8⁺ T cell memory precursor effector cells and antimelanoma memory responses are the result of vaccination and TGF-beta blockade during the perioperative period of tumor resection. J. Immunol. 186:3309–16
     [Google Scholar]
157. 157.

     Sanjabi S, Mosaheb MM, Flavell RA. 2009. Opposing effects of TGF-beta and IL-15 cytokines control the number of short-lived effector CD8⁺ T cells. Immunity 31:131–44
     [Google Scholar]
158. 158.

     Gate D, Danielpour M, Rodriguez J Jr., Kim GB, Levy R et al. 2014. T-cell TGF-beta signaling abrogation restricts medulloblastoma progression. PNAS 111:E3458–66
     [Google Scholar]
159. 159.

     Wallberg M, Wong FS, Green EA. 2011. An islet-specific pulse of TGF-beta abrogates CTL function and promotes beta cell survival independent of Foxp3⁺ T cells. J. Immunol. 186:2543–51
     [Google Scholar]
160. 160.

     Zhang N, Bevan MJ. 2012. TGF-beta signaling to T cells inhibits autoimmunity during lymphopenia-driven proliferation. Nat. Immunol. 13:667–73
     [Google Scholar]
161. 161.

     Bromley SK, Akbaba H, Mani V, Mora-Buch R, Chasse AY et al. 2020. CD49a regulates cutaneous resident memory CD8⁺ T cell persistence and response. Cell Rep. 32:108085
     [Google Scholar]
162. 162.

     Mackay LK, Rahimpour A, Ma JZ, Collins N, Stock AT et al. 2013. The developmental pathway for CD103⁺CD8⁺ tissue-resident memory T cells of skin. Nat. Immunol. 14:1294–301
     [Google Scholar]
163. 163.

     Sheridan BS, Pham QM, Lee YT, Cauley LS, Puddington L, Lefrancois L. 2014. Oral infection drives a distinct population of intestinal resident memory CD8⁺ T cells with enhanced protective function. Immunity 40:747–57
     [Google Scholar]
164. 164.

     Borges da Silva H, Peng C, Wang H, Wanhainen KM, Ma C et al. 2020. Sensing of ATP via the purinergic receptor P2RX7 promotes CD8⁺ Trm cell generation by enhancing their sensitivity to the cytokine TGF-β. Immunity 53:158–71.e6
     [Google Scholar]
165. 165.

     Laidlaw BJ, Zhang N, Marshall HD, Staron MM, Guan T et al. 2014. CD4⁺ T cell help guides formation of CD103⁺ lung-resident memory CD8⁺ T cells during influenza viral infection. Immunity 41:633–45
     [Google Scholar]
166. 166.

     Wu J, Madi A, Mieg A, Hotz-Wagenblatt A, Weisshaar N et al. 2020. T cell factor 1 suppresses CD103⁺ lung tissue-resident memory T cell development. Cell Rep. 31:107484
     [Google Scholar]
167. 167.

     Qiu Z, Chu TH, Sheridan BS. 2021. TGF-β: many paths to CD103⁺ CD8 T cell residency. Cells 10:989
     [Google Scholar]
168. 168.

     Loi JK, Alexandre YO, Senthil K, Schienstock D, Sandford S et al. 2022. Corneal tissue-resident memory T cells form a unique immune compartment at the ocular surface. Cell Rep. 39:110852
     [Google Scholar]
169. 169.

     Ray SJ, Franki SN, Pierce RH, Dimitrova S, Koteliansky V et al. 2004. The collagen binding α1β1 integrin VLA-1 regulates CD8 T cell-mediated immune protection against heterologous influenza infection. Immunity 20:167–79
     [Google Scholar]
170. 170.

     Skon CN, Lee JY, Anderson KG, Masopust D, Hogquist KA, Jameson SC. 2013. Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8⁺ T cells. Nat. Immunol. 14:1285–93
     [Google Scholar]
171. 171.

     Mani V, Bromley SK, Aijo T, Mora-Buch R, Carrizosa E et al. 2019. Migratory DCs activate TGF-β to precondition naïve CD8⁺ T cells for tissue-resident memory fate. Science 366:eaav5728
     [Google Scholar]
172. 172.

     Ferreira C, Barros L, Baptista M, Blankenhaus B, Barros A et al. 2020. Type 1 Treg cells promote the generation of CD8⁺ tissue-resident memory T cells. Nat. Immunol. 21:766–76
     [Google Scholar]
173. 173.

     Malenica I, Adam J, Corgnac S, Mezquita L, Auclin E et al. 2021. Integrin-α_V-mediated activation of TGF-β regulates anti-tumour CD8 T cell immunity and response to PD-1 blockade. Nat. Commun. 12:5209
     [Google Scholar]
174. 174.

     Kallies A, Zehn D, Utzschneider DT. 2020. Precursor exhausted T cells: key to successful immunotherapy?. Nat. Rev. Immunol. 20:128–36
     [Google Scholar]
175. 175.

     Chatterjee S, Chatterjee A, Jana S, Dey S, Roy H et al. 2021. Transforming growth factor beta orchestrates PD-L1 enrichment in tumor-derived exosomes and mediates CD8 T-cell dysfunction regulating early phosphorylation of TCR signalome in breast cancer. Carcinogenesis 42:38–47
     [Google Scholar]
176. 176.

     Giordano M, Henin C, Maurizio J, Imbratta C, Bourdely P et al. 2015. Molecular profiling of CD8 T cells in autochthonous melanoma identifies Maf as driver of exhaustion. EMBO J. 34:2042–58
     [Google Scholar]
177. 177.

     Smith CJ, Snyder CM. 2021. Inhibitory molecules PD-1, CD73 and CD39 are expressed by CD8⁺ T cells in a tissue-dependent manner and can inhibit T cell responses to stimulation. Front. Immunol. 12:704862
     [Google Scholar]
178. 178.

     Stephen TL, Rutkowski MR, Allegrezza MJ, Perales-Puchalt A, Tesone AJ et al. 2014. Transforming growth factor beta-mediated suppression of antitumor T cells requires FoxP1 transcription factor expression. Immunity 41:427–39
     [Google Scholar]
179. 179.

     Tinoco R, Alcalde V, Yang Y, Sauer K, Zuniga EI. 2009. Cell-intrinsic transforming growth factor-beta signaling mediates virus-specific CD8⁺ T cell deletion and viral persistence in vivo. Immunity 31:145–57
     [Google Scholar]
180. 180.

     Gabriel SS, Tsui C, Chisanga D, Weber F, Llano-Leon M et al. 2021. Transforming growth factor-beta-regulated mTOR activity preserves cellular metabolism to maintain long-term T cell responses in chronic infection. Immunity 54:1698–714.e5
     [Google Scholar]
181. 181.

     Pomie C, Menager-Marcq I, van Meerwijk JP. 2008. Murine CD8⁺ regulatory T lymphocytes: the new era. Hum. Immunol. 69:708–14
     [Google Scholar]
182. 182.

     Kim HJ, Verbinnen B, Tang X, Lu L, Cantor H. 2010. Inhibition of follicular T-helper cells by CD8⁺ regulatory T cells is essential for self tolerance. Nature 467:328–32
     [Google Scholar]
183. 183.

     Li J, Zaslavsky M, Su Y, Guo J, Sikora MJ et al. 2022. KIR⁺CD8⁺ T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19. Science 376:eabi9591
     [Google Scholar]
184. 184.

     Du J, Yang H, Zhang D, Wang J, Guo H et al. 2010. Structural basis for the blockage of IL-2 signaling by therapeutic antibody basiliximab. J. Immunol. 184:1361–68
     [Google Scholar]
185. 185.

     Hu B, Jin C, Zeng X, Resch JM, Jedrychowski MP et al. 2020. γδ T cells and adipocyte IL-17RC control fat innervation and thermogenesis. Nature 578:610–14
     [Google Scholar]
186. 186.

     Peters C, Hasler R, Wesch D, Kabelitz D. 2016. Human Vδ2 T cells are a major source of interleukin-9. PNAS 113:12520–25
     [Google Scholar]
187. 187.

     Bendelac A, Savage PB, Teyton L. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25:297–336
     [Google Scholar]
188. 188.

     Chuang YH, Lian ZX, Yang GX, Shu SA, Moritoki Y et al. 2008. Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis. Hepatology 47:571–80
     [Google Scholar]
189. 189.

     Monteiro M, Agua-Doce A, Almeida CF, Fonseca-Pereira D, Veiga-Fernandes H, Graca L. 2015. IL-9 expression by invariant NKT cells is not imprinted during thymic development. J. Immunol. 195:3463–71
     [Google Scholar]
190. 190.

     McDonald BD, Jabri B, Bendelac A. 2018. Diverse developmental pathways of intestinal intraepithelial lymphocytes. Nat. Rev. Immunol. 18:514–25
     [Google Scholar]
191. 191.

     Suzuki R, Nakao A, Kanamaru Y, Okumura K, Ogawa H, Ra C. 2002. Localization of intestinal intraepithelial T lymphocytes involves regulation of αEβ7 expression by transforming growth factor-β. Int. Immunol. 14:339–45
     [Google Scholar]
192. 192.

     Lim SP, Leung E, Krissansen GW. 1998. The β7 integrin gene (Itgb-7) promoter is responsive to TGF-β1: defining control regions. Immunogenetics 48:184–95
     [Google Scholar]
193. 193.

     Verstichel G, Vermijlen D, Martens L, Goetgeluk G, Brouwer M et al. 2017. The checkpoint for agonist selection precedes conventional selection in human thymus. Sci. Immunol. 2:eaah4232
     [Google Scholar]
194. 194.

     Das G, Augustine MM, Das J, Bottomly K, Ray P, Ray A 2003. An important regulatory role for CD4⁺CD8αα T cells in the intestinal epithelial layer in the prevention of inflammatory bowel disease. PNAS 100:5324–29
     [Google Scholar]
195. 195.

     Mucida D, Husain MM, Muroi S, van Wijk F, Shinnakasu R et al. 2013. Transcriptional reprogramming of mature CD4⁺ helper T cells generates distinct MHC class II-restricted cytotoxic T lymphocytes. Nat. Immunol. 14:281–89
     [Google Scholar]
196. 196.

     Reis BS, Rogoz A, Costa-Pinto FA, Taniuchi I, Mucida D. 2013. Mutual expression of the transcription factors Runx3 and ThPOK regulates intestinal CD4⁺ T cell immunity. Nat. Immunol. 14:271–80
     [Google Scholar]
197. 197.

     Sujino T, London M, Hoytema van Konijnenburg DP, Rendon T, Buch T et al. 2016. Tissue adaptation of regulatory and intraepithelial CD4⁺ T cells controls gut inflammation. Science 352:1581–86
     [Google Scholar]
198. 198.

     Cortez VS, Cervantes-Barragan L, Robinette ML, Bando JK, Wang Y et al. 2016. Transforming growth factor-β signaling guides the differentiation of innate lymphoid cells in salivary glands. Immunity 44:1127–39
     [Google Scholar]
199. 199.

     Cortez VS, Ulland TK, Cervantes-Barragan L, Bando JK, Robinette ML et al. 2017. SMAD4 impedes the conversion of NK cells into ILC1-like cells by curtailing non-canonical TGF-beta signaling. Nat. Immunol. 18:995–1003
     [Google Scholar]
200. 200.

     Gao Y, Souza-Fonseca-Guimaraes F, Bald T, Ng SS, Young A et al. 2017. Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells. Nat. Immunol. 18:1004–15
     [Google Scholar]
201. 201.

     Nixon BG, Chou C, Krishna C, Dadi S, Michel AO et al. 2022. Cytotoxic granzyme C-expressing ILC1s contribute to antitumor immunity and neonatal autoimmunity. Sci. Immunol. 7:eabi8642
     [Google Scholar]
202. 202.

     Hawke LG, Mitchell BZ, Ormiston ML. 2020. TGF-beta and IL-15 synergize through MAPK pathways to drive the conversion of human NK cells to an innate lymphoid cell 1-like phenotype. J. Immunol. 204:3171–81
     [Google Scholar]
203. 203.

     Jowett GM, Norman MDA, Yu TTL, Rosell Arevalo P, Hoogland D et al. 2021. ILC1 drive intestinal epithelial and matrix remodelling. Nat. Mater. 20:250–59
     [Google Scholar]
204. 204.

     Wang L, Tang J, Yang X, Zanvit P, Cui K et al. 2020. TGF-beta induces ST2 and programs ILC2 development. Nat. Commun. 11:35
     [Google Scholar]
205. 205.

     Zhang J, Qiu J, Zhou W, Cao J, Hu X et al. 2022. Neuropilin-1 mediates lung tissue-specific control of ILC2 function in type 2 immunity. Nat. Immunol. 23:237–50
     [Google Scholar]
206. 206.

     Laurent P, Allard B, Manicki P, Jolivel V, Levionnois E et al. 2021. TGFβ promotes low IL10-producing ILC2 with profibrotic ability involved in skin fibrosis in systemic sclerosis. Ann. Rheum. Dis. 80:1594–603
     [Google Scholar]
207. 207.

     Bernink JH, Ohne Y, Teunissen MBM, Wang J, Wu J et al. 2019. c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies. Nat. Immunol. 20:992–1003
     [Google Scholar]
208. 208.

     Chea S, Perchet T, Petit M, Verrier T, Guy-Grand D et al. 2016. Notch signaling in group 3 innate lymphoid cells modulates their plasticity. Sci. Signal. 9:ra45
     [Google Scholar]
209. 209.

     Viant C, Rankin LC, Girard-Madoux MJ, Seillet C, Shi W et al. 2016. Transforming growth factor-beta and Notch ligands act as opposing environmental cues in regulating the plasticity of type 3 innate lymphoid cells. Sci. Signal. 9:ra46
     [Google Scholar]
210. 210.

     Wang S, Xia P, Chen Y, Qu Y, Xiong Z et al. 2017. Regulatory innate lymphoid cells control innate intestinal inflammation. Cell 171:201–16.e18
     [Google Scholar]